Prostate-Specific Membrane Antigen-Targeted Turn-on Probe for Imaging Cargo Release in Prostate Cancer Cells

被引:9
|
作者
Olatunji, Feyisola P. [1 ]
Savoy, Emily A. [1 ]
Panteah, Mylan [2 ]
Mesbahi, Nooshin [1 ]
Abbasi, Armina [1 ]
Talley, Cresencia M. [1 ]
Lovingier, Christine L. [1 ]
Caromile, Leslie A. [2 ]
Berkman, Clifford E. [1 ]
机构
[1] Washington State Univ, Dept Chem, Pullman, WA 99164 USA
[2] UCONN Hlth Ctr Vasc Biol, Farmington, CT 06030 USA
基金
美国国家卫生研究院;
关键词
MONOCLONAL-ANTIBODY; FOLATE HYDROLASE; TUMOR-CELLS; PH; INHIBITOR; PSMA; PET; INTERNALIZATION; THERAPY; APTAMER;
D O I
10.1021/acs.bioconjchem.1c00435
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The tunable nature of phosphoramidate linkers enables broad applicability as pH-triggered controlled-release platforms, particularly in the context of antibody-and small-molecule-drug conjugates (ADCs and SMDCs), where there remains a need for new linker technology. Herein, we explored in-depth the release of turn-on fluorogenic payloads from a homoserinyl-based phosphoramidate acid-cleavable linker. Kinetics of payload release from the scaffold was observed in buffers representing the pH conditions of systemic circulation, early and late endosomes, and lysosomes. It was found that payload release takes place in two key consecutive steps: (1) P-N bond hydrolysis and (2) spacer immolation. These two steps were found to follow pseudo-first-order kinetics and had opposite dependencies on pH. P-N bond hydrolysis increased with decreasing pH, while spacer immolation was most rapid at physiological pH. Despite the contrasting release kinetics of these two steps, maximal payload release was observed at the mildly acidic pH (5.0-5.5), while minimal payload release occurred at physiological pH. We integrated this phosphoramidate-payload linker system into a PSMA-targeted fluorescent turn-on probe to study the intracellular trafficking and release of a fluorescent payload in PSMA-expressing prostate cancer cells. Results showed excellent turn-on and accumulation of the coumarin payload in the late endosomal and lysosomal compartments of these cells. The release properties of this linker mark it as an attractive alternative in the modular design of ADCs and SMDCs, which demand selective intracellular payload release triggered by the pH changes that accompany intracellular trafficking.
引用
收藏
页码:2386 / 2396
页数:11
相关论文
共 50 条
  • [41] Long-Circulating Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostic Agent
    Overchuk, Marta
    Damen, Martha P. F.
    Harmatys, Kara M.
    Pomper, Martin G.
    Chen, Juan
    Zheng, Gang
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2020, 96 (03) : 718 - 724
  • [42] Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer
    Mangadlao, Joey Dacula
    Wang, Xinning
    McCleese, Christopher
    Escamilla, Maria
    Ramamurthy, Gopalakrishnan
    Wang, Ziying
    Govande, Mukul
    Basilion, James P.
    Burda, Clemens
    ACS NANO, 2018, 12 (04) : 3714 - 3725
  • [43] Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer
    Michael Sun
    Muhammad Junaid Niaz
    Muhammad Obaid Niaz
    Scott T. Tagawa
    Current Oncology Reports, 2021, 23
  • [44] Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer
    Sun, Michael
    Niaz, Muhammad Junaid
    Niaz, Muhammad Obaid
    Tagawa, Scott T.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (05)
  • [45] Advances in Prostate-Specific Membrane Antigen (PSMA)-Targeted Phototheranostics of Prostate Cancer
    Wang, He
    He, Zhangxin
    Liu, Xiao-Ang
    Huang, Yuhua
    Hou, Jianquan
    Zhang, Weijie
    Ding, Dan
    SMALL STRUCTURES, 2022, 3 (08):
  • [46] 18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer Correlation With Multiparametric MRI and Histopathology
    Turkbey, Baris
    Mena, Esther
    Lindenberg, Liza
    Adler, Stephen
    Bednarova, Sandra
    Berman, Rose
    Ton, Anita T.
    McKinney, Yolanda
    Eclarinal, Philip
    Hill, Craig
    Afari, George
    Bhattacharyya, Sibaprasad
    Mease, Ronnie C.
    Merino, Maria J.
    Jacobs, Paula M.
    Wood, Bradford J.
    Pinto, Peter A.
    Pomper, Martin G.
    Choyke, Peter L.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) : 735 - 740
  • [47] Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI
    Pu, Fan
    Salarian, Mani
    Xue, Shenghui
    Qiao, Jingjuan
    Feng, Jie
    Tan, Shanshan
    Patel, Anvi
    Li, Xin
    Mamouni, Kenza
    Hekmatyar, Khan
    Zou, Juan
    Wu, Daqing
    Yang, Jenny J.
    NANOSCALE, 2016, 8 (25) : 12668 - 12682
  • [48] Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls
    Sheikhbahaei, Sara
    Werner, Rudolf A.
    Solnes, Lilja B.
    Pienta, Kenneth J.
    Pomper, Martin G.
    Gorin, Michael A.
    Rowe, Steven P.
    SEMINARS IN NUCLEAR MEDICINE, 2019, 49 (04) : 255 - 270
  • [49] Prostate-Specific Membrane Antigen-Targeted Imaging With [18F] DCFPyL in High-Grade Gliomas
    Fragomeni, Roberto Andres Salas
    Menke, Joshua R.
    Holdhoff, Matthias
    Ferrigno, Clare
    Laterra, John Joseph
    Solnes, Lilja B.
    Javadi, Mehrbod S.
    Szabo, Zsolt
    Pomper, Martin G.
    Rowe, Steven P.
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) : E433 - E435
  • [50] Preclinical Evaluation of a Fibroblast Activation Protein and a Prostate-Specific Membrane Antigen Dual-Targeted Probe for Noninvasive Prostate Cancer Imaging
    Wang, Pei
    Wang, Shuailiang
    Liu, Futao
    Ren, Ya'nan
    Guo, Qian
    Zhang, Qian
    Hou, XingGuo
    Yao, Yuan
    Zhu, Hua
    Yang, Zhi
    MOLECULAR PHARMACEUTICS, 2023, : 1415 - 1425